nodes	percent_of_prediction	percent_of_DWPC	metapath
Hyoscyamine—Rash papular—Vemurafenib—melanoma	0.0253	0.0421	CcSEcCtD
Hyoscyamine—Cocaine—SCN11A—melanoma	0.0199	0.678	CrCbGaD
Hyoscyamine—Hyperaemia—Carmustine—melanoma	0.0165	0.0275	CcSEcCtD
Hyoscyamine—Electrocardiogram QT prolonged—Vemurafenib—melanoma	0.0147	0.0244	CcSEcCtD
Hyoscyamine—Paralysis—Vemurafenib—melanoma	0.0136	0.0226	CcSEcCtD
Hyoscyamine—Rash maculo-papular—Vemurafenib—melanoma	0.00857	0.0143	CcSEcCtD
Hyoscyamine—Visual acuity reduced—Temozolomide—melanoma	0.0081	0.0135	CcSEcCtD
Hyoscyamine—Sinus tachycardia—Docetaxel—melanoma	0.00796	0.0132	CcSEcCtD
Hyoscyamine—Cocaine—SCN10A—melanoma	0.0075	0.255	CrCbGaD
Hyoscyamine—Paranoia—Carmustine—melanoma	0.00732	0.0122	CcSEcCtD
Hyoscyamine—Atrial fibrillation—Vemurafenib—melanoma	0.00723	0.012	CcSEcCtD
Hyoscyamine—Stupor—Carmustine—melanoma	0.00668	0.0111	CcSEcCtD
Hyoscyamine—Dry skin—Vemurafenib—melanoma	0.00628	0.0104	CcSEcCtD
Hyoscyamine—Petechiae—Temozolomide—melanoma	0.00586	0.00974	CcSEcCtD
Hyoscyamine—Speech disorder—Carmustine—melanoma	0.0058	0.00964	CcSEcCtD
Hyoscyamine—Speech disorder—Temozolomide—melanoma	0.0056	0.00932	CcSEcCtD
Hyoscyamine—Skin exfoliation—Bleomycin—melanoma	0.00546	0.00907	CcSEcCtD
Hyoscyamine—Leukocytosis—Carmustine—melanoma	0.00531	0.00882	CcSEcCtD
Hyoscyamine—Injection site reaction—Carmustine—melanoma	0.00496	0.00824	CcSEcCtD
Hyoscyamine—Respiratory failure—Temozolomide—melanoma	0.00491	0.00816	CcSEcCtD
Hyoscyamine—Supraventricular tachycardia—Docetaxel—melanoma	0.00489	0.00813	CcSEcCtD
Hyoscyamine—Depressed level of consciousness—Carmustine—melanoma	0.00482	0.00801	CcSEcCtD
Hyoscyamine—Skin exfoliation—Carmustine—melanoma	0.00476	0.00792	CcSEcCtD
Hyoscyamine—Haemoglobin decreased—Docetaxel—melanoma	0.00466	0.00774	CcSEcCtD
Hyoscyamine—Heartburn—Docetaxel—melanoma	0.00466	0.00774	CcSEcCtD
Hyoscyamine—Depressed level of consciousness—Temozolomide—melanoma	0.00466	0.00774	CcSEcCtD
Hyoscyamine—Disorientation—Bleomycin—melanoma	0.00464	0.00771	CcSEcCtD
Hyoscyamine—Skin exfoliation—Temozolomide—melanoma	0.0046	0.00765	CcSEcCtD
Hyoscyamine—Coma—Carmustine—melanoma	0.00456	0.00758	CcSEcCtD
Hyoscyamine—Dry eye—Temozolomide—melanoma	0.00445	0.0074	CcSEcCtD
Hyoscyamine—Rash erythematous—Docetaxel—melanoma	0.00419	0.00696	CcSEcCtD
Hyoscyamine—Erythema—Vemurafenib—melanoma	0.00412	0.00686	CcSEcCtD
Hyoscyamine—Swelling—Carmustine—melanoma	0.0041	0.00682	CcSEcCtD
Hyoscyamine—Dysgeusia—Vemurafenib—melanoma	0.00404	0.00671	CcSEcCtD
Hyoscyamine—Eye pain—Carmustine—melanoma	0.00401	0.00667	CcSEcCtD
Hyoscyamine—Ageusia—Docetaxel—melanoma	0.00396	0.00658	CcSEcCtD
Hyoscyamine—Lethargy—Dactinomycin—melanoma	0.00395	0.00656	CcSEcCtD
Hyoscyamine—Eye pain—Temozolomide—melanoma	0.00388	0.00644	CcSEcCtD
Hyoscyamine—Amnesia—Carmustine—melanoma	0.00385	0.00641	CcSEcCtD
Hyoscyamine—Nasal congestion—Temozolomide—melanoma	0.00384	0.00639	CcSEcCtD
Hyoscyamine—Amnesia—Temozolomide—melanoma	0.00372	0.00619	CcSEcCtD
Hyoscyamine—Thirst—Temozolomide—melanoma	0.00368	0.00611	CcSEcCtD
Hyoscyamine—Hyponatraemia—Carmustine—melanoma	0.00364	0.00604	CcSEcCtD
Hyoscyamine—Ataxia—Carmustine—melanoma	0.0034	0.00566	CcSEcCtD
Hyoscyamine—Anaphylactic shock—Vemurafenib—melanoma	0.00337	0.0056	CcSEcCtD
Hyoscyamine—Dysphagia—Dactinomycin—melanoma	0.00334	0.00556	CcSEcCtD
Hyoscyamine—Hypokalaemia—Carmustine—melanoma	0.0033	0.00548	CcSEcCtD
Hyoscyamine—Ataxia—Temozolomide—melanoma	0.00329	0.00547	CcSEcCtD
Hyoscyamine—Respiratory failure—Docetaxel—melanoma	0.00326	0.00543	CcSEcCtD
Hyoscyamine—Dehydration—Temozolomide—melanoma	0.00325	0.00541	CcSEcCtD
Hyoscyamine—Dry skin—Temozolomide—melanoma	0.00321	0.00533	CcSEcCtD
Hyoscyamine—Blood pressure increased—Docetaxel—melanoma	0.00321	0.00533	CcSEcCtD
Hyoscyamine—Injection site reaction—Docetaxel—melanoma	0.00319	0.0053	CcSEcCtD
Hyoscyamine—Hypokalaemia—Temozolomide—melanoma	0.00318	0.00529	CcSEcCtD
Hyoscyamine—Acute coronary syndrome—Bleomycin—melanoma	0.00315	0.00524	CcSEcCtD
Hyoscyamine—Hypotension—Vemurafenib—melanoma	0.00314	0.00523	CcSEcCtD
Hyoscyamine—Myocardial infarction—Bleomycin—melanoma	0.00313	0.00521	CcSEcCtD
Hyoscyamine—Dysphagia—Carmustine—melanoma	0.00313	0.0052	CcSEcCtD
Hyoscyamine—Skin exfoliation—Docetaxel—melanoma	0.00306	0.00509	CcSEcCtD
Hyoscyamine—Abdominal distension—Temozolomide—melanoma	0.00304	0.00506	CcSEcCtD
Hyoscyamine—Dysphagia—Temozolomide—melanoma	0.00302	0.00503	CcSEcCtD
Hyoscyamine—Fatigue—Vemurafenib—melanoma	0.0029	0.00482	CcSEcCtD
Hyoscyamine—Constipation—Vemurafenib—melanoma	0.00288	0.00478	CcSEcCtD
Hyoscyamine—Pulmonary oedema—Docetaxel—melanoma	0.00285	0.00474	CcSEcCtD
Hyoscyamine—Dysuria—Temozolomide—melanoma	0.00283	0.0047	CcSEcCtD
Hyoscyamine—Hyperglycaemia—Carmustine—melanoma	0.00282	0.00469	CcSEcCtD
Hyoscyamine—Erectile dysfunction—Temozolomide—melanoma	0.00279	0.00463	CcSEcCtD
Hyoscyamine—Depression—Carmustine—melanoma	0.00278	0.00463	CcSEcCtD
Hyoscyamine—Hyperglycaemia—Temozolomide—melanoma	0.00273	0.00454	CcSEcCtD
Hyoscyamine—Depression—Temozolomide—melanoma	0.00269	0.00447	CcSEcCtD
Hyoscyamine—Flushing—Bleomycin—melanoma	0.00266	0.00443	CcSEcCtD
Hyoscyamine—Body temperature increased—Vemurafenib—melanoma	0.00266	0.00442	CcSEcCtD
Hyoscyamine—Swelling—Docetaxel—melanoma	0.00264	0.00439	CcSEcCtD
Hyoscyamine—Erythema—Bleomycin—melanoma	0.0025	0.00415	CcSEcCtD
Hyoscyamine—Hallucination—Carmustine—melanoma	0.00249	0.00414	CcSEcCtD
Hyoscyamine—Flushing—Dactinomycin—melanoma	0.00248	0.00413	CcSEcCtD
Hyoscyamine—Hypersensitivity—Vemurafenib—melanoma	0.00248	0.00412	CcSEcCtD
Hyoscyamine—Atrial fibrillation—Docetaxel—melanoma	0.00246	0.00408	CcSEcCtD
Hyoscyamine—Asthenia—Vemurafenib—melanoma	0.00241	0.00401	CcSEcCtD
Hyoscyamine—Hallucination—Temozolomide—melanoma	0.00241	0.004	CcSEcCtD
Hyoscyamine—Pruritus—Vemurafenib—melanoma	0.00238	0.00396	CcSEcCtD
Hyoscyamine—Lethargy—Docetaxel—melanoma	0.00237	0.00395	CcSEcCtD
Hyoscyamine—Hyponatraemia—Docetaxel—melanoma	0.00234	0.00388	CcSEcCtD
Hyoscyamine—Erythema—Dactinomycin—melanoma	0.00233	0.00387	CcSEcCtD
Hyoscyamine—Flushing—Carmustine—melanoma	0.00232	0.00387	CcSEcCtD
Hyoscyamine—Diarrhoea—Vemurafenib—melanoma	0.0023	0.00383	CcSEcCtD
Hyoscyamine—Flushing—Temozolomide—melanoma	0.00225	0.00374	CcSEcCtD
Hyoscyamine—Arrhythmia—Carmustine—melanoma	0.00224	0.00372	CcSEcCtD
Hyoscyamine—Dizziness—Vemurafenib—melanoma	0.00223	0.0037	CcSEcCtD
Hyoscyamine—Mental disorder—Carmustine—melanoma	0.00219	0.00365	CcSEcCtD
Hyoscyamine—Ataxia—Docetaxel—melanoma	0.00219	0.00364	CcSEcCtD
Hyoscyamine—Erythema—Carmustine—melanoma	0.00218	0.00363	CcSEcCtD
Hyoscyamine—Dehydration—Docetaxel—melanoma	0.00216	0.0036	CcSEcCtD
Hyoscyamine—Vomiting—Vemurafenib—melanoma	0.00214	0.00356	CcSEcCtD
Hyoscyamine—Dry skin—Docetaxel—melanoma	0.00213	0.00355	CcSEcCtD
Hyoscyamine—Chest pain—Bleomycin—melanoma	0.00213	0.00354	CcSEcCtD
Hyoscyamine—Rash—Vemurafenib—melanoma	0.00212	0.00353	CcSEcCtD
Hyoscyamine—Mental disorder—Temozolomide—melanoma	0.00212	0.00353	CcSEcCtD
Hyoscyamine—Dermatitis—Vemurafenib—melanoma	0.00212	0.00352	CcSEcCtD
Hyoscyamine—Headache—Vemurafenib—melanoma	0.00211	0.00351	CcSEcCtD
Hyoscyamine—Erythema—Temozolomide—melanoma	0.00211	0.0035	CcSEcCtD
Hyoscyamine—Dysgeusia—Temozolomide—melanoma	0.00206	0.00343	CcSEcCtD
Hyoscyamine—Confusional state—Bleomycin—melanoma	0.00206	0.00342	CcSEcCtD
Hyoscyamine—Vision blurred—Carmustine—melanoma	0.00206	0.00342	CcSEcCtD
Hyoscyamine—Anaphylactic shock—Bleomycin—melanoma	0.00204	0.00339	CcSEcCtD
Hyoscyamine—Oedema—Bleomycin—melanoma	0.00204	0.00339	CcSEcCtD
Hyoscyamine—Dysphagia—Docetaxel—melanoma	0.00201	0.00334	CcSEcCtD
Hyoscyamine—Agitation—Carmustine—melanoma	0.002	0.00333	CcSEcCtD
Hyoscyamine—Nausea—Vemurafenib—melanoma	0.002	0.00332	CcSEcCtD
Hyoscyamine—Vision blurred—Temozolomide—melanoma	0.00199	0.0033	CcSEcCtD
Hyoscyamine—Angina pectoris—Docetaxel—melanoma	0.00196	0.00326	CcSEcCtD
Hyoscyamine—Scopolamine—ABCB1—melanoma	0.00195	0.0663	CrCbGaD
Hyoscyamine—Agitation—Temozolomide—melanoma	0.00194	0.00322	CcSEcCtD
Hyoscyamine—Angioedema—Temozolomide—melanoma	0.00193	0.0032	CcSEcCtD
Hyoscyamine—Hypotension—Bleomycin—melanoma	0.00191	0.00317	CcSEcCtD
Hyoscyamine—Oedema—Dactinomycin—melanoma	0.0019	0.00316	CcSEcCtD
Hyoscyamine—Vertigo—Temozolomide—melanoma	0.00189	0.00315	CcSEcCtD
Hyoscyamine—Convulsion—Carmustine—melanoma	0.00189	0.00314	CcSEcCtD
Hyoscyamine—Palpitations—Temozolomide—melanoma	0.00186	0.0031	CcSEcCtD
Hyoscyamine—Chest pain—Carmustine—melanoma	0.00186	0.00309	CcSEcCtD
Hyoscyamine—Anxiety—Carmustine—melanoma	0.00185	0.00308	CcSEcCtD
Hyoscyamine—Convulsion—Temozolomide—melanoma	0.00183	0.00304	CcSEcCtD
Hyoscyamine—Dyspnoea—Bleomycin—melanoma	0.00182	0.00302	CcSEcCtD
Hyoscyamine—Confusional state—Carmustine—melanoma	0.00179	0.00298	CcSEcCtD
Hyoscyamine—Anxiety—Temozolomide—melanoma	0.00179	0.00297	CcSEcCtD
Hyoscyamine—Oedema—Carmustine—melanoma	0.00178	0.00296	CcSEcCtD
Hyoscyamine—Acute coronary syndrome—Docetaxel—melanoma	0.00177	0.00294	CcSEcCtD
Hyoscyamine—Myocardial infarction—Docetaxel—melanoma	0.00176	0.00292	CcSEcCtD
Hyoscyamine—Dry mouth—Temozolomide—melanoma	0.00175	0.00292	CcSEcCtD
Hyoscyamine—Pain—Bleomycin—melanoma	0.00174	0.0029	CcSEcCtD
Hyoscyamine—Conjunctivitis—Docetaxel—melanoma	0.00174	0.0029	CcSEcCtD
Hyoscyamine—Tachycardia—Carmustine—melanoma	0.00174	0.00289	CcSEcCtD
Hyoscyamine—Confusional state—Temozolomide—melanoma	0.00173	0.00288	CcSEcCtD
Hyoscyamine—Anaphylactic shock—Temozolomide—melanoma	0.00172	0.00286	CcSEcCtD
Hyoscyamine—Oedema—Temozolomide—melanoma	0.00172	0.00286	CcSEcCtD
Hyoscyamine—Feeling abnormal—Bleomycin—melanoma	0.00168	0.00279	CcSEcCtD
Hyoscyamine—Hypotension—Carmustine—melanoma	0.00166	0.00276	CcSEcCtD
Hyoscyamine—Hyperhidrosis—Temozolomide—melanoma	0.00166	0.00276	CcSEcCtD
Hyoscyamine—Fatigue—Dactinomycin—melanoma	0.00164	0.00273	CcSEcCtD
Hyoscyamine—Pain—Dactinomycin—melanoma	0.00163	0.0027	CcSEcCtD
Hyoscyamine—Urticaria—Bleomycin—melanoma	0.00162	0.00269	CcSEcCtD
Hyoscyamine—Body temperature increased—Bleomycin—melanoma	0.00161	0.00268	CcSEcCtD
Hyoscyamine—Insomnia—Carmustine—melanoma	0.00161	0.00268	CcSEcCtD
Hyoscyamine—Dyspnoea—Carmustine—melanoma	0.00159	0.00264	CcSEcCtD
Hyoscyamine—Somnolence—Carmustine—melanoma	0.00158	0.00263	CcSEcCtD
Hyoscyamine—Feeling abnormal—Dactinomycin—melanoma	0.00157	0.00261	CcSEcCtD
Hyoscyamine—Insomnia—Temozolomide—melanoma	0.00156	0.00259	CcSEcCtD
Hyoscyamine—Gastrointestinal pain—Dactinomycin—melanoma	0.00155	0.00259	CcSEcCtD
Hyoscyamine—Dyspnoea—Temozolomide—melanoma	0.00153	0.00255	CcSEcCtD
Hyoscyamine—Somnolence—Temozolomide—melanoma	0.00153	0.00254	CcSEcCtD
Hyoscyamine—Pain—Carmustine—melanoma	0.00152	0.00253	CcSEcCtD
Hyoscyamine—Constipation—Carmustine—melanoma	0.00152	0.00253	CcSEcCtD
Hyoscyamine—Dyspepsia—Temozolomide—melanoma	0.00151	0.00252	CcSEcCtD
Hyoscyamine—Abdominal pain—Dactinomycin—melanoma	0.0015	0.0025	CcSEcCtD
Hyoscyamine—Body temperature increased—Dactinomycin—melanoma	0.0015	0.0025	CcSEcCtD
Hyoscyamine—Hypersensitivity—Bleomycin—melanoma	0.0015	0.0025	CcSEcCtD
Hyoscyamine—Flushing—Docetaxel—melanoma	0.00149	0.00248	CcSEcCtD
Hyoscyamine—Fatigue—Temozolomide—melanoma	0.00148	0.00247	CcSEcCtD
Hyoscyamine—Constipation—Temozolomide—melanoma	0.00147	0.00245	CcSEcCtD
Hyoscyamine—Pain—Temozolomide—melanoma	0.00147	0.00245	CcSEcCtD
Hyoscyamine—Feeling abnormal—Carmustine—melanoma	0.00147	0.00244	CcSEcCtD
Hyoscyamine—Asthenia—Bleomycin—melanoma	0.00146	0.00243	CcSEcCtD
Hyoscyamine—Gastrointestinal pain—Carmustine—melanoma	0.00146	0.00242	CcSEcCtD
Hyoscyamine—Pruritus—Bleomycin—melanoma	0.00144	0.0024	CcSEcCtD
Hyoscyamine—Arrhythmia—Docetaxel—melanoma	0.00144	0.00239	CcSEcCtD
Hyoscyamine—Feeling abnormal—Temozolomide—melanoma	0.00142	0.00236	CcSEcCtD
Hyoscyamine—Mental disorder—Docetaxel—melanoma	0.00141	0.00234	CcSEcCtD
Hyoscyamine—Abdominal pain—Carmustine—melanoma	0.00141	0.00234	CcSEcCtD
Hyoscyamine—Body temperature increased—Carmustine—melanoma	0.00141	0.00234	CcSEcCtD
Hyoscyamine—Gastrointestinal pain—Temozolomide—melanoma	0.00141	0.00234	CcSEcCtD
Hyoscyamine—Erythema—Docetaxel—melanoma	0.0014	0.00233	CcSEcCtD
Hyoscyamine—Hypersensitivity—Dactinomycin—melanoma	0.0014	0.00233	CcSEcCtD
Hyoscyamine—Dysgeusia—Docetaxel—melanoma	0.00137	0.00228	CcSEcCtD
Hyoscyamine—Urticaria—Temozolomide—melanoma	0.00137	0.00227	CcSEcCtD
Hyoscyamine—Asthenia—Dactinomycin—melanoma	0.00136	0.00227	CcSEcCtD
Hyoscyamine—Abdominal pain—Temozolomide—melanoma	0.00136	0.00226	CcSEcCtD
Hyoscyamine—Body temperature increased—Temozolomide—melanoma	0.00136	0.00226	CcSEcCtD
Hyoscyamine—Hypersensitivity—Carmustine—melanoma	0.00131	0.00218	CcSEcCtD
Hyoscyamine—Diarrhoea—Dactinomycin—melanoma	0.0013	0.00216	CcSEcCtD
Hyoscyamine—Vomiting—Bleomycin—melanoma	0.0013	0.00216	CcSEcCtD
Hyoscyamine—Rash—Bleomycin—melanoma	0.00129	0.00214	CcSEcCtD
Hyoscyamine—Dermatitis—Bleomycin—melanoma	0.00128	0.00214	CcSEcCtD
Hyoscyamine—Asthenia—Carmustine—melanoma	0.00128	0.00212	CcSEcCtD
Hyoscyamine—Hypersensitivity—Temozolomide—melanoma	0.00127	0.00211	CcSEcCtD
Hyoscyamine—Syncope—Docetaxel—melanoma	0.00126	0.00209	CcSEcCtD
Hyoscyamine—Palpitations—Docetaxel—melanoma	0.00124	0.00206	CcSEcCtD
Hyoscyamine—Asthenia—Temozolomide—melanoma	0.00123	0.00205	CcSEcCtD
Hyoscyamine—Loss of consciousness—Docetaxel—melanoma	0.00123	0.00205	CcSEcCtD
Hyoscyamine—Diarrhoea—Carmustine—melanoma	0.00122	0.00202	CcSEcCtD
Hyoscyamine—Pruritus—Temozolomide—melanoma	0.00122	0.00202	CcSEcCtD
Hyoscyamine—Convulsion—Docetaxel—melanoma	0.00121	0.00202	CcSEcCtD
Hyoscyamine—Nausea—Bleomycin—melanoma	0.00121	0.00201	CcSEcCtD
Hyoscyamine—Vomiting—Dactinomycin—melanoma	0.00121	0.00201	CcSEcCtD
Hyoscyamine—Rash—Dactinomycin—melanoma	0.0012	0.00199	CcSEcCtD
Hyoscyamine—Chest pain—Docetaxel—melanoma	0.00119	0.00198	CcSEcCtD
Hyoscyamine—Dizziness—Carmustine—melanoma	0.00118	0.00196	CcSEcCtD
Hyoscyamine—Diarrhoea—Temozolomide—melanoma	0.00118	0.00196	CcSEcCtD
Hyoscyamine—Dry mouth—Docetaxel—melanoma	0.00117	0.00194	CcSEcCtD
Hyoscyamine—Confusional state—Docetaxel—melanoma	0.00115	0.00192	CcSEcCtD
Hyoscyamine—Anaphylactic shock—Docetaxel—melanoma	0.00114	0.0019	CcSEcCtD
Hyoscyamine—Oedema—Docetaxel—melanoma	0.00114	0.0019	CcSEcCtD
Hyoscyamine—Dizziness—Temozolomide—melanoma	0.00114	0.00189	CcSEcCtD
Hyoscyamine—Vomiting—Carmustine—melanoma	0.00113	0.00188	CcSEcCtD
Hyoscyamine—Nausea—Dactinomycin—melanoma	0.00113	0.00188	CcSEcCtD
Hyoscyamine—Shock—Docetaxel—melanoma	0.00113	0.00187	CcSEcCtD
Hyoscyamine—Rash—Carmustine—melanoma	0.00112	0.00187	CcSEcCtD
Hyoscyamine—Dermatitis—Carmustine—melanoma	0.00112	0.00186	CcSEcCtD
Hyoscyamine—Tachycardia—Docetaxel—melanoma	0.00112	0.00186	CcSEcCtD
Hyoscyamine—Headache—Carmustine—melanoma	0.00111	0.00185	CcSEcCtD
Hyoscyamine—Vomiting—Temozolomide—melanoma	0.00109	0.00182	CcSEcCtD
Hyoscyamine—Rash—Temozolomide—melanoma	0.00108	0.0018	CcSEcCtD
Hyoscyamine—Dermatitis—Temozolomide—melanoma	0.00108	0.0018	CcSEcCtD
Hyoscyamine—Headache—Temozolomide—melanoma	0.00108	0.00179	CcSEcCtD
Hyoscyamine—Hypotension—Docetaxel—melanoma	0.00107	0.00178	CcSEcCtD
Hyoscyamine—Nausea—Carmustine—melanoma	0.00106	0.00176	CcSEcCtD
Hyoscyamine—Insomnia—Docetaxel—melanoma	0.00103	0.00172	CcSEcCtD
Hyoscyamine—Nausea—Temozolomide—melanoma	0.00102	0.0017	CcSEcCtD
Hyoscyamine—Dyspnoea—Docetaxel—melanoma	0.00102	0.0017	CcSEcCtD
Hyoscyamine—Somnolence—Docetaxel—melanoma	0.00102	0.00169	CcSEcCtD
Hyoscyamine—Dyspepsia—Docetaxel—melanoma	0.00101	0.00167	CcSEcCtD
Hyoscyamine—Fatigue—Docetaxel—melanoma	0.000986	0.00164	CcSEcCtD
Hyoscyamine—Pain—Docetaxel—melanoma	0.000978	0.00163	CcSEcCtD
Hyoscyamine—Constipation—Docetaxel—melanoma	0.000978	0.00163	CcSEcCtD
Hyoscyamine—Feeling abnormal—Docetaxel—melanoma	0.000943	0.00157	CcSEcCtD
Hyoscyamine—Gastrointestinal pain—Docetaxel—melanoma	0.000935	0.00155	CcSEcCtD
Hyoscyamine—Abdominal pain—Docetaxel—melanoma	0.000904	0.0015	CcSEcCtD
Hyoscyamine—Body temperature increased—Docetaxel—melanoma	0.000904	0.0015	CcSEcCtD
Hyoscyamine—Hypersensitivity—Docetaxel—melanoma	0.000843	0.0014	CcSEcCtD
Hyoscyamine—Asthenia—Docetaxel—melanoma	0.000821	0.00136	CcSEcCtD
Hyoscyamine—Pruritus—Docetaxel—melanoma	0.000809	0.00135	CcSEcCtD
Hyoscyamine—Diarrhoea—Docetaxel—melanoma	0.000783	0.0013	CcSEcCtD
Hyoscyamine—Dizziness—Docetaxel—melanoma	0.000756	0.00126	CcSEcCtD
Hyoscyamine—Vomiting—Docetaxel—melanoma	0.000727	0.00121	CcSEcCtD
Hyoscyamine—Rash—Docetaxel—melanoma	0.000721	0.0012	CcSEcCtD
Hyoscyamine—Dermatitis—Docetaxel—melanoma	0.000721	0.0012	CcSEcCtD
Hyoscyamine—Headache—Docetaxel—melanoma	0.000717	0.00119	CcSEcCtD
Hyoscyamine—Nausea—Docetaxel—melanoma	0.000679	0.00113	CcSEcCtD
Hyoscyamine—CHRM3—Signaling Pathways—CD86—melanoma	7.48e-05	0.000203	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR downstream signaling—CXCL8—melanoma	7.48e-05	0.000203	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—EDN1—melanoma	7.45e-05	0.000202	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—EDN1—melanoma	7.42e-05	0.000201	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—IGF1—melanoma	7.42e-05	0.000201	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—CD86—melanoma	7.41e-05	0.000201	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR downstream signaling—CXCL8—melanoma	7.41e-05	0.000201	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling by GPCR—MAPK1—melanoma	7.39e-05	0.0002	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling by GPCR—EGFR—melanoma	7.39e-05	0.0002	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—EDN1—melanoma	7.35e-05	0.000199	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—CSF2—melanoma	7.28e-05	0.000197	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—FGF1—melanoma	7.28e-05	0.000197	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—FGF1—melanoma	7.26e-05	0.000197	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—CSF2—melanoma	7.26e-05	0.000197	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—FGF1—melanoma	7.19e-05	0.000195	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—CSF2—melanoma	7.19e-05	0.000195	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—MAP2K1—melanoma	7.17e-05	0.000194	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR downstream signaling—IL2—melanoma	7.17e-05	0.000194	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR downstream signaling—IL2—melanoma	7.15e-05	0.000194	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—PIK3CD—melanoma	7.13e-05	0.000193	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—E2F1—melanoma	7.12e-05	0.000193	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—E2F1—melanoma	7.1e-05	0.000192	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—PIK3CB—melanoma	7.09e-05	0.000192	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR downstream signaling—IL2—melanoma	7.08e-05	0.000192	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—PIK3CB—melanoma	7.07e-05	0.000191	CbGpPWpGaD
Hyoscyamine—CHRM4—GPCR downstream signaling—PIK3CA—melanoma	7.06e-05	0.000191	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—PDGFRA—melanoma	7.05e-05	0.000191	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—E2F1—melanoma	7.03e-05	0.00019	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—PDGFRA—melanoma	7.03e-05	0.00019	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—PIK3CB—melanoma	7e-05	0.00019	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—ITGB3—melanoma	6.98e-05	0.000189	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—PRKCA—melanoma	6.98e-05	0.000189	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling by GPCR—KRAS—melanoma	6.98e-05	0.000189	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—PDGFRA—melanoma	6.96e-05	0.000189	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—PRKCA—melanoma	6.96e-05	0.000188	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—ITGB3—melanoma	6.96e-05	0.000188	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—ITGB3—melanoma	6.89e-05	0.000187	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—PRKCA—melanoma	6.89e-05	0.000187	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—SPP1—melanoma	6.84e-05	0.000185	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—FGF2—melanoma	6.82e-05	0.000185	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—MAP2K2—melanoma	6.82e-05	0.000185	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—SPP1—melanoma	6.82e-05	0.000185	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—CXCL8—melanoma	6.81e-05	0.000185	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—MAP2K2—melanoma	6.8e-05	0.000184	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—CXCL8—melanoma	6.79e-05	0.000184	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—SPP1—melanoma	6.76e-05	0.000183	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—MAP2K2—melanoma	6.73e-05	0.000182	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—CXCL8—melanoma	6.73e-05	0.000182	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—PIK3CG—melanoma	6.52e-05	0.000177	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—IL2—melanoma	6.51e-05	0.000176	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—IL2—melanoma	6.49e-05	0.000176	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—TERT—melanoma	6.49e-05	0.000176	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—RAC1—melanoma	6.47e-05	0.000175	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—TERT—melanoma	6.47e-05	0.000175	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—RAC1—melanoma	6.45e-05	0.000175	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—IL2—melanoma	6.43e-05	0.000174	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling by GPCR—PIK3CA—melanoma	6.41e-05	0.000174	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—TERT—melanoma	6.4e-05	0.000174	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—RAC1—melanoma	6.39e-05	0.000173	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—MDM2—melanoma	6.39e-05	0.000173	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—ERBB2—melanoma	6.3e-05	0.000171	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—PPARG—melanoma	6.29e-05	0.00017	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—PIK3CB—melanoma	6.21e-05	0.000168	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—HIF1A—melanoma	6.21e-05	0.000168	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—HIF1A—melanoma	6.19e-05	0.000168	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—HIF1A—melanoma	6.13e-05	0.000166	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—CXCL8—melanoma	5.97e-05	0.000162	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—KDR—melanoma	5.93e-05	0.000161	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling by GPCR—HRAS—melanoma	5.93e-05	0.000161	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—KDR—melanoma	5.92e-05	0.00016	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—KDR—melanoma	5.86e-05	0.000159	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—CDKN1B—melanoma	5.83e-05	0.000158	CbGpPWpGaD
Hyoscyamine—CHRM4—GPCR downstream signaling—AKT1—melanoma	5.77e-05	0.000156	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—PIK3CD—melanoma	5.73e-05	0.000155	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—CASP3—melanoma	5.71e-05	0.000155	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—FN1—melanoma	5.71e-05	0.000155	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—IL2—melanoma	5.71e-05	0.000155	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—FN1—melanoma	5.69e-05	0.000154	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling by GPCR—IL6—melanoma	5.68e-05	0.000154	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—ALB—melanoma	5.66e-05	0.000153	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—FN1—melanoma	5.64e-05	0.000153	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—NOTCH1—melanoma	5.59e-05	0.000151	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—NOTCH1—melanoma	5.57e-05	0.000151	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—CCND1—melanoma	5.56e-05	0.000151	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—NOTCH1—melanoma	5.52e-05	0.000149	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—CTNNB1—melanoma	5.51e-05	0.000149	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—CD80—melanoma	5.48e-05	0.000148	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—APC—melanoma	5.47e-05	0.000148	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—PIK3CG—melanoma	5.47e-05	0.000148	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—KIT—melanoma	5.47e-05	0.000148	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—NRAS—melanoma	5.47e-05	0.000148	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—CD80—melanoma	5.46e-05	0.000148	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—APC—melanoma	5.45e-05	0.000148	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—KIT—melanoma	5.45e-05	0.000148	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—PIK3CG—melanoma	5.45e-05	0.000148	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—NRAS—melanoma	5.45e-05	0.000148	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—CD80—melanoma	5.41e-05	0.000146	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—EGF—melanoma	5.4e-05	0.000146	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—MMP9—melanoma	5.4e-05	0.000146	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—APC—melanoma	5.4e-05	0.000146	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—PIK3CG—melanoma	5.4e-05	0.000146	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—KIT—melanoma	5.4e-05	0.000146	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—NRAS—melanoma	5.4e-05	0.000146	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—EGF—melanoma	5.39e-05	0.000146	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—CDKN1A—melanoma	5.38e-05	0.000146	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—PTEN—melanoma	5.37e-05	0.000145	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—NFKB1—melanoma	5.34e-05	0.000145	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—EGF—melanoma	5.33e-05	0.000144	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling by GPCR—AKT1—melanoma	5.24e-05	0.000142	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—MAPK3—melanoma	5.24e-05	0.000142	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—MAPK3—melanoma	5.22e-05	0.000141	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—MAPK3—melanoma	5.17e-05	0.00014	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—BRAF—melanoma	5.14e-05	0.000139	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—BRAF—melanoma	5.12e-05	0.000139	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—BRAF—melanoma	5.07e-05	0.000137	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—IGF1—melanoma	5.01e-05	0.000136	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—PIK3CB—melanoma	4.99e-05	0.000135	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—IGF1—melanoma	4.99e-05	0.000135	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—MAPK1—melanoma	4.98e-05	0.000135	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—EGFR—melanoma	4.98e-05	0.000135	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—MAPK1—melanoma	4.97e-05	0.000135	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—EGFR—melanoma	4.96e-05	0.000134	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—PTGS2—melanoma	4.95e-05	0.000134	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—IGF1—melanoma	4.94e-05	0.000134	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—MAPK1—melanoma	4.92e-05	0.000133	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—EGFR—melanoma	4.92e-05	0.000133	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—VEGFA—melanoma	4.85e-05	0.000131	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—MAP2K1—melanoma	4.84e-05	0.000131	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—MAP2K1—melanoma	4.82e-05	0.000131	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—PIK3CD—melanoma	4.81e-05	0.00013	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—STAT3—melanoma	4.8e-05	0.00013	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—PIK3CD—melanoma	4.79e-05	0.00013	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—NRAS—melanoma	4.79e-05	0.00013	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—MAP2K1—melanoma	4.78e-05	0.000129	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR downstream signaling—PIK3CA—melanoma	4.76e-05	0.000129	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR downstream signaling—PIK3CA—melanoma	4.74e-05	0.000129	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—PIK3CD—melanoma	4.74e-05	0.000129	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—KRAS—melanoma	4.7e-05	0.000127	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR downstream signaling—PIK3CA—melanoma	4.7e-05	0.000127	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—KRAS—melanoma	4.69e-05	0.000127	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—KRAS—melanoma	4.64e-05	0.000126	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—FGF2—melanoma	4.6e-05	0.000125	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—MAPK3—melanoma	4.59e-05	0.000124	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—FGF2—melanoma	4.59e-05	0.000124	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—FGF2—melanoma	4.54e-05	0.000123	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—MYC—melanoma	4.46e-05	0.000121	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—MAPK1—melanoma	4.36e-05	0.000118	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—EGFR—melanoma	4.36e-05	0.000118	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—PIK3CA—melanoma	4.32e-05	0.000117	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—PTEN—melanoma	4.32e-05	0.000117	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—PIK3CA—melanoma	4.31e-05	0.000117	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—MDM2—melanoma	4.31e-05	0.000117	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—MDM2—melanoma	4.29e-05	0.000116	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—PIK3CA—melanoma	4.27e-05	0.000116	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—MDM2—melanoma	4.25e-05	0.000115	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—ERBB2—melanoma	4.24e-05	0.000115	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—ERBB2—melanoma	4.23e-05	0.000115	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—ERBB2—melanoma	4.19e-05	0.000114	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—PIK3CB—melanoma	4.19e-05	0.000113	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—PIK3CB—melanoma	4.18e-05	0.000113	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—PIK3CB—melanoma	4.13e-05	0.000112	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—KRAS—melanoma	4.12e-05	0.000112	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—CXCL8—melanoma	4.03e-05	0.000109	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—CXCL8—melanoma	4.01e-05	0.000109	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—HRAS—melanoma	4e-05	0.000108	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—HRAS—melanoma	3.99e-05	0.000108	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—CXCL8—melanoma	3.97e-05	0.000108	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—HRAS—melanoma	3.95e-05	0.000107	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—CDKN1B—melanoma	3.93e-05	0.000106	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—CDKN1B—melanoma	3.92e-05	0.000106	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR downstream signaling—AKT1—melanoma	3.89e-05	0.000105	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—CDKN1B—melanoma	3.88e-05	0.000105	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR downstream signaling—AKT1—melanoma	3.88e-05	0.000105	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—CASP3—melanoma	3.85e-05	0.000104	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—IL2—melanoma	3.85e-05	0.000104	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—CASP3—melanoma	3.84e-05	0.000104	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR downstream signaling—AKT1—melanoma	3.84e-05	0.000104	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—IL2—melanoma	3.83e-05	0.000104	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—IL6—melanoma	3.83e-05	0.000104	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—IL6—melanoma	3.82e-05	0.000103	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—CASP3—melanoma	3.8e-05	0.000103	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—IL2—melanoma	3.8e-05	0.000103	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—PIK3CA—melanoma	3.79e-05	0.000103	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—IL6—melanoma	3.78e-05	0.000102	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—CCND1—melanoma	3.75e-05	0.000102	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—CCND1—melanoma	3.74e-05	0.000101	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—CTNNB1—melanoma	3.71e-05	0.000101	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—CCND1—melanoma	3.7e-05	0.0001	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—CTNNB1—melanoma	3.7e-05	0.0001	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—CTNNB1—melanoma	3.67e-05	9.93e-05	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—TP53—melanoma	3.66e-05	9.92e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—MMP9—melanoma	3.64e-05	9.86e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—MMP9—melanoma	3.63e-05	9.83e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—CDKN1A—melanoma	3.63e-05	9.83e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—PTEN—melanoma	3.62e-05	9.81e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—CDKN1A—melanoma	3.62e-05	9.8e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—PTEN—melanoma	3.61e-05	9.77e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—NFKB1—melanoma	3.6e-05	9.76e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—MMP9—melanoma	3.59e-05	9.74e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—NFKB1—melanoma	3.59e-05	9.73e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—CDKN1A—melanoma	3.58e-05	9.7e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—PTEN—melanoma	3.57e-05	9.68e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—NFKB1—melanoma	3.56e-05	9.63e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—AKT1—melanoma	3.53e-05	9.57e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—AKT1—melanoma	3.52e-05	9.54e-05	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—HRAS—melanoma	3.5e-05	9.49e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—AKT1—melanoma	3.49e-05	9.44e-05	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—IL6—melanoma	3.35e-05	9.08e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—VEGFA—melanoma	3.27e-05	8.86e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—VEGFA—melanoma	3.26e-05	8.83e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—STAT3—melanoma	3.24e-05	8.77e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—NRAS—melanoma	3.23e-05	8.75e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—VEGFA—melanoma	3.23e-05	8.74e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—STAT3—melanoma	3.23e-05	8.74e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—NRAS—melanoma	3.22e-05	8.72e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—STAT3—melanoma	3.2e-05	8.66e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—NRAS—melanoma	3.19e-05	8.64e-05	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—AKT1—melanoma	3.09e-05	8.38e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—MAPK3—melanoma	3.09e-05	8.38e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—MAPK3—melanoma	3.08e-05	8.35e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—MAPK3—melanoma	3.05e-05	8.27e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—PIK3CA—melanoma	3.04e-05	8.25e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—MYC—melanoma	3.01e-05	8.15e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—MYC—melanoma	3e-05	8.12e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—MYC—melanoma	2.97e-05	8.04e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—MAPK1—melanoma	2.94e-05	7.97e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—EGFR—melanoma	2.94e-05	7.97e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—MAPK1—melanoma	2.93e-05	7.95e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—EGFR—melanoma	2.93e-05	7.94e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—MAPK1—melanoma	2.9e-05	7.87e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—EGFR—melanoma	2.9e-05	7.87e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—KRAS—melanoma	2.78e-05	7.53e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—KRAS—melanoma	2.77e-05	7.51e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—KRAS—melanoma	2.74e-05	7.43e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—PIK3CA—melanoma	2.55e-05	6.92e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—PIK3CA—melanoma	2.55e-05	6.9e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—PIK3CA—melanoma	2.52e-05	6.83e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—AKT1—melanoma	2.49e-05	6.74e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—TP53—melanoma	2.47e-05	6.69e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—TP53—melanoma	2.46e-05	6.67e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—TP53—melanoma	2.44e-05	6.61e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—HRAS—melanoma	2.36e-05	6.4e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—HRAS—melanoma	2.35e-05	6.38e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—HRAS—melanoma	2.33e-05	6.32e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—IL6—melanoma	2.26e-05	6.13e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—IL6—melanoma	2.25e-05	6.11e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—IL6—melanoma	2.23e-05	6.05e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—AKT1—melanoma	2.09e-05	5.65e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—AKT1—melanoma	2.08e-05	5.63e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—AKT1—melanoma	2.06e-05	5.58e-05	CbGpPWpGaD
